Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

J Clin Immunol. 2022 Apr;42(3):512-513. doi: 10.1007/s10875-022-01219-3.
No abstract available

Publication types

  • Published Erratum